Menu
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Where Will Novavax Be in 1 Year?


What a difference a few months make. Vaccine specialist (NASDAQ: NVAX) started the year poorly, continuing with the issues it has encountered since mid-2021.

Those headwinds included the difficulties it faced in launching its COVID vaccine in the U.S. and the significant slowdown in demand for these products, leading to a decline in revenue and earnings for the biotech.

However, several developments have jolted Novavax's stock since January. The company's shares are up by just under 200% this year. Can it keep up that momentum through the next 12 months? Let's find out.

Continue reading


Source Fool.com

Novavax Inc. Stock

€7.13
3.940%
A very strong showing by Novavax Inc. today, with an increase of €0.27 (3.940%) compared to yesterday's price.
Our community is currently high on Novavax Inc. with 8 Buy predictions and 3 Sell predictions.
With a target price of 11 € there is a hugely positive potential of 54.28% for Novavax Inc. compared to the current price of 7.13 €.
Like: 0
Share

Comments